CS logo
small CS logo
The Ottawa Hospital; Division of Infectious Diseases

Ottawa, Ontario, Canada
General hospital in Ottawa, Ontario
1053 Carling Ave, Ottawa, ON K1Y 4E9
549 Beds

About The Ottawa Hospital; Division of Infectious Diseases


The Ottawa Civic Hospital is one of three main campuses of The Ottawa Hospital – along with the General and Riverside campuses. With 549 beds, the Civic Campus has the region's only adult-care trauma centre, serving Eastern Ontario, the Outaouais region of Quebec and eastern Nunavut.
There are 549 beds in The Ottawa Hospital; Division of Infectious Diseases.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at The Ottawa Hospital; Division of Infectious Diseases


During the past decade, The Ottawa Hospital; Division of Infectious Diseases conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cardiovascular Inflammation Reduction Trial
2013-04-01
2019-10-30
Completed
4,786
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
2014-01-24
2018-05-14
Completed
14,673
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
2014-10-28
2017-07-10
Completed
746
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins
2014-06-01
2015-11-01
Completed
184
Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
2014-07-22
2017-06-05
Completed
2,725
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988

Rows per page:

1–16 of 16

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "The Ottawa Hospital; Division of Infectious Diseases" #1 collaborator was "German Breast Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at The Ottawa Hospital; Division of Infectious Diseases


According to Clinical.Site data, the most researched conditions in "The Ottawa Hospital; Division of Infectious Diseases" are "Breast Cancer" (1 trials), "Chronic Hepatitis B" (1 trials) and "Malignant Melanoma" (1 trials). Many other conditions were trialed in "The Ottawa Hospital; Division of Infectious Diseases" in a lesser frequency.

Clinical Trials Intervention Types at The Ottawa Hospital; Division of Infectious Diseases


Most popular intervention types in "The Ottawa Hospital; Division of Infectious Diseases" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Peg-IFN" (1 trials), "TDF" (1 trials), "Vemurafenib" (1 trials), "trastuzumab" (1 trials) and "trastuzumab emtansine" (1 trials). Other intervention names were less common.

Clinical Trials Genders at The Ottawa Hospital; Division of Infectious Diseases


The vast majority of trials in "The Ottawa Hospital; Division of Infectious Diseases" are 3 trials for "All" genders.

Clinical Trials Status at The Ottawa Hospital; Division of Infectious Diseases


Currently, there are NaN active trials in "The Ottawa Hospital; Division of Infectious Diseases". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in The Ottawa Hospital; Division of Infectious Diseases, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The Ottawa Hospital; Division of Infectious Diseases, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status